Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

197
Delayed Quote. Delayed London Stock Exchange - 05/06 07:14:17 am
1519 GBp   +1.23%
07:24a New-look GSK bets on consumer health spending
07:22a GlaxoSmithKline targets growth across units, scraps ViiV IPO
07:08a GLAXOSMITHKLINE : Results announcement for the first quarter 2015
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201220132014201520162017
Sales26 43126 50523 00624 41425 06225 770
Operating income (EBITDA)9 4158 8838 0457 7207 9708 298
Operating profit (EBIT)8 3308 0156 5946 0466 4636 968
Pre-Tax Profit (EBT)6 6926 6472 9684 3374 8625 110
Net income4 5655 6282 7563 0723 3113 667
EPS (PNC)91,511156,768,466,977,9
Dividend per Share (PNC)74,078,080,080,680,181,2
Yield4,93%5,20%5,33%5,37%5,34%5,41%
Announcement Date02/06/2013
12:01pm
02/05/2014
12:00pm
02/04/2015
03:18pm
---
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201220132014201520162017
Debt14 03712 64514 37712 98413 60313 870
Finance------
Operating income (EBITDA)9 4158 8838 0457 7207 9708 298
Leverage
(Debt/EBITDA)
1,49x1,42x1,79x1,68x1,71x1,67x
Capital Expenditure1 0511 1881 1882 0081 4311 542
Book Value Per Share (BVPS)120 PNC146 PNC87,6 PNC92,7 PNC75,2 PNC58,5 PNC
Cash Flow per Share87,7 PNC149 PNC108 PNC103 PNC110 PNC122 PNC
Announcement Date02/06/2013
12:01pm
02/05/2014
12:00pm
02/04/2015
03:18pm
---
Balance Sheet Analysis
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 72 719 M GBP -
Entreprise Value (EV) 85 704 M GBP 86 322 M GBP
Valuation 2015e 2016e
PER (Price / EPS) 21,9x 22,4x
Capitalization / Revenue 2,98x 2,90x
EV / Revenue 3,51x 3,44x
EV / EBITDA 11,1x 10,8x
Yield (DPS / Price) 5,37% 5,34%
Price to book (Price / BVPS) 16,2x 19,9x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 24,8% 25,8%
operating Leverage (Delta EBIT / Delta Sales) - 2,60x
Net Margin (Net Profit / Revenue) 12,6% 13,2%
ROA (Net Profit / Asset) 7,70% 9,30%
ROE (Net Profit / Equities) 88,0% 111%
Rate of Dividend 118% 120%
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   8,22% 5,71%
Cash Flow / Sales (Taux d'autofinancement) 20,5% 21,3%
Capital Intensity (Assets / Sales) 1,63x 1,42x
Financial Leverage (Net Debt / EBITDA) 1,68x 1,71x
Price Earning Ratio
EPS & Dividend
Dynamic quotes  
ON
| OFF